Evidence map›Paper›PMID 40880432›Full record

ArticlePLoS genetics2025

Igf2 adult-specific skeletal muscle enhancer activity revealed in mice with intergenic CTCF boundary deletion.

Joanne L Thorvaldsen, Aimee M Juan, Yemin Lan, Christopher Krapp, Marisa S Bartolomei

Abstract read
In one paragraph

Article in PLoS genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Long Noncoding RNANon-coding RNA · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joanne L ThorvaldsenUniversity of Pennsylvania Perelman School of Medicine, Epigenetics Institute, Department of Cell and Developmental Biology, Philadelphia, Pennsylvania, United States of America.
Aimee M JuanUniversity of Pennsylvania Perelman School of Medicine, Epigenetics Institute, Department of Cell and Developmental Biology, Philadelphia, Pennsylvania, United States of America.
Yemin LanUniversity of Pennsylvania Perelman School of Medicine, Epigenetics Institute, Department of Cell and Developmental Biology, Philadelphia, Pennsylvania, United States of America.
Christopher KrappUniversity of Pennsylvania Perelman School of Medicine, Epigenetics Institute, Department of Cell and Developmental Biology, Philadelphia, Pennsylvania, United States of America.
Marisa S BartolomeiUniversity of Pennsylvania Perelman School of Medicine, Epigenetics Institute, Department of Cell and Developmental Biology, Philadelphia, Pennsylvania, United States of America.ORCID https://orcid.org/0000-0001-9410-5222

Funding

SEQUENCES CONTROLLING H19 GENE IMPRINTINGR01GM051279 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S. · 1994 to 2024
$5.1M
Graduate Training in Developmental BiologyT32HD083185 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI Michael Granato, Foteini Mourkioti · 2015 to 2026
$4.0M
Sequences controlling H19 Gene ImprintingR37GM051279 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S. · 2011 to 2020
$3.9M
Investigating the Epigenetic Regulation of Imprinted Gene Grb10 in NeurodevelopmentF31HD095583 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI JUAN, AIMEE · 2018 to 2019
$38k
NICHD NIH HHS F31 HD095583NICHD NIH HHS T32 HD083185NIGMS NIH HHS R01 GM051279NIGMS NIH HHS R37 GM051279
6 · The paper itself

Abstract

Precise, monoallelic expression of imprinted genes is governed by cis regulatory elements called imprinting control regions (ICRs) and enhancer-promoter (E-P) interactions shaped by local chromatin architecture. The Igf2/H19 locus employs allele-specific CTCF binding at the ICR to instruct enhancer accessibility to maternal H19 and paternal Igf2 promoters. Here, we investigate the CTCF-bound centrally conserved domain (CCD), intergenic to H19 and Igf2, and an adjacent widely expressed lncRNA. Using transgenic mice, deletion alleles reinforced CCD as a neonatal muscle-specific repressor of maternal Igf2. However, deletion of the abutting lncRNA did not affect Igf2 levels. Unexpectedly, in adult skeletal muscle where Igf2 is normally repressed, absence of CCD resulted in remarkable, high-level activation of Igf2 from both parental alleles. Through multimodal chromatin analyses, we identified a conserved putative adult skeletal muscle enhancer (PaSME) insulated between chromatin domains at ICR and CCD. We propose that removal of CCD allows PaSME to drive robust abnormal Igf2 activation on both alleles in adult skeletal muscle. Thus, we uncover CCD as a developmental biallelic muscle-specific repressor, adding a new layer of architectural regulation to the extensively studied Igf2/H19 locus.

Indexed as

CCCTC-Binding FactorEnhancer Elements, GeneticInsulin-Like Growth Factor IIMuscle, SkeletalAllelesAnimalsChromatinGene Expression Regulation, DevelopmentalGenomic ImprintingMiceMice, TransgenicPromoter Regions, GeneticRNA, Long NoncodingCCCTC-Binding FactorChromatinCtcf protein, mouseH19 long non-coding RNAIGF2 protein, mouseInsulin-Like Growth Factor IIRNA, Long Noncoding

Identifiers

PMID40880432
PMCPMC12416839

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.